Cholesterol conjugated spermine as a delivery modality of antisense oligonucleotide
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The major issue in the development of nucleic acid based therapeutics is the inefficient delivery of these agents into cells. We prepared cholesterol conjugated spermine and evaluated its usefulness as a delivery modality for antisense oligonucleotides in HeLa-Luc cells. A 2’-O-methyl antisense oligonucleotide sequence, designed to correct splicing at an aberrant intron inserted into a normal luciferase reporter gene, was used for complex formation with cholesterol conjugated spermine. Effective delivery of this antisense agent into nucleus would results in the expression of a luciferasereporter gene product. The cholesterol-spermine formed stable complexes with the antisense oligonucleotide and showed modest delivery activity. Furthermore, this delivery activity was maintained even in the presence of serum proteins, mimicking in vivo conditions. Cholesterol-spermine thus has potential as a delivery system for antisense oligonucleotides into cells.
Abstract
The major issue in the development of nucleic acid based therapeutics is the inefficient delivery of these agents into cells. We prepared cholesterol conjugated spermine and evaluated its usefulness as a delivery modality for antisense oligonucleotides in HeLa-Luc cells. A 2’-O-methyl antisense oligonucleotide sequence, designed to correct splicing at an aberrant intron inserted into a normal luciferase reporter gene, was used for complex formation with cholesterol conjugated spermine. Effective delivery of this antisense agent into nucleus would results in the expression of a luciferasereporter gene product. The cholesterol-spermine formed stable complexes with the antisense oligonucleotide and showed modest delivery activity. Furthermore, this delivery activity was maintained even in the presence of serum proteins, mimicking in vivo conditions. Cholesterol-spermine thus has potential as a delivery system for antisense oligonucleotides into cells.
참고문헌 (29)
- Juliano RL, "Liposomes as a drug delivery system for antisense oligonucleotides", Antisense Res Dev, 2, pp.165~176 (1992)
- Gao X, "Cationic liposome-mediated gene transfer", Gene Ther, 2, pp.710~722 (1995)
- Gao X, "Potentiation of cationic liposome- mediated gene delivery by polycations", Biochemistry, 35, pp.1027~1036 (1996)
- Alahari SK, "Novel chemically modified oligonucleotides provide potent inhibition of P-glycoprotein expression", J Pharmacol Exp Ther, 286, pp.419~428 (1998)
- Bennett CF, "Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides", Mol Pharmacol, 41, pp.1023~1033 (1992)
- Betts CA, "Cell penetrating Peptide delivery of splice directing oligonucleotides as a treatment for duchenne muscular dystrophy", Curr Pharm Des, 19, pp.2948~2962 (2013)
- Degols G, "Sequence-specific activity of antisense oligonucleotides conjugated to poly (L-lysine) carriers", Ann N Y Acad Sci, 660, pp.331~333 (1992)
- Yoo H, "Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers", Nucleic Acids Res, 28, pp.4225~4231 (2000)
- Liang E, "Characterization of a pH-sensitive surfactant, dodecyl-2-(1'-imidazolyl) propionate (DIP), and preliminary studies in liposome mediated gene transfer", Biochim Biophys Acta, 1369, pp.39~50 (1998)
- Alahari SK, "Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides", Mol Pharmacol, 50, pp.808~819 (1996)
- DeLong RK, "Novel cationic amphiphiles as delivery agents for antisense oligonucleotides", Nucleic Acids Res, 27, pp.3334~3341 (1999)
- Rajur SB, "Covalent protein-oligonucleotide conjugates for efficient delivery of antisense molecules", Bioconjug Chem, 8, pp.935~940 (1997)
- Juliano R, "Biological barriers to therapy with antisense and siRNA oligonucleotides", Mol Pharm, 6, pp.686~695 (2009)
- Zelphati O, "Mechanism of oligonucleotide release from cationic liposomes", Proc Natl Acad Sci U S A, 93, pp.11493~11498 (1996)
- Juliano RL, "The chemistry and biology of oligonucleotide conjugates", Acc Chem Res, 45, pp.1067~1076 (2012)
- Wong FM, "A lipid-based delivery system for antisense oligonucleotides derived from a hydrophobic complex", J Drug Target, 10, pp.615~623 (2002)
- Elbashir SM, "Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells", Nature, 411, pp.494~498 (2001)
- Huang L, "The role of carrier size in the pharmacodynamics of antisense and siRNA oligonucleotides", J Drug Target, 18, pp.567~574 (2010)
- Elbashir SM, "RNA interference is mediated by 21- and 22-nucleotide RNAs", Genes Dev, 15, pp.188~200 (2001)
- Juliano RL, "Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides", Bioconjug Chem, 23, pp.147~157 (2012)
- Meidan VM, "Specific lipoplex-mediated antisense against Bcl-2 in breast cancer cells: a comparison between different formulations", J Liposome Res, 16, pp.27~43 (2006)
- Bahadur KCR, "Design of serum compatible tetrary complexes for gene delivery", Macromol Biosci, 12, pp.637~646 (2012)
- Duan SY, "Synthetic polyspermine imidazole-4, 5-amide as an efficient and cytotoxicity-free gene delivery system", Int J Nanomedicine, 7, pp.3813~3822 (2012)
- Gagnon KT, "Antisense and antigene inhibition of gene expression by cell-permeable oligonucleotide- oligospermine conjugates", J Am Chem Soc, 133, pp.8404~8407 (2011)
- Lacomino G, "DNA and nuclear aggregates of polyamines", Biochim Biophys Acta, 1823, pp.1745~1755 (2012)
- Maslov MA, "Novel cholesterol spermine conjugates provide efficient cellular delivery of plasmid DNA and small interfering RNA", J Control Release, 160, pp.182~193 (2012)
- Kang SH, "Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development", Biochemistry, 37, pp.6235~6239 (1998)
- Yoo H, "PAMAM dendrimers as delivery agents for antisense oligonucleotides", Pharm Res, 16, pp.1799~1804 (1999)
- Felber AE, "The interactions of amphiphilic antisense oligonucleotides with serum proteins and their effects on in vitro silencing activity", Biomaterials, 33, pp.5955~5965 (2012)